Investors
Press Releases
Press releases issued by Palatin are accessible below. These press releases contain additional information about our business, clinical trial developments, research and development activities, financial achievements, and strategic partnerships.
Found 317 Results
Palatin Technologies Receives Patent Strengthening Its Melanocortin Peptide Intellectual Property
June 6, 2016
Palatin Technologies Receives Patent Strengthening Its Melanocortin Peptide Intellectual Property
May 26, 2016
Palatin Technologies Presents Bremelanotide Alcohol Interaction Study at International Society for the Study of Women’s Sexual Health Annual Meeting
February 26, 2016
Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2016 Results; Teleconference and Webcast to be held on February 16, 2016
February 16, 2016
Palatin Technologies Strengthens Intellectual Property Surrounding Use of Bremelanotide for Female Sexual Dysfunction
February 8, 2016
Palatin Technologies To Present At The BIO CEO & Investor Conference
February 4, 2016
Page 20 of 32